Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,167 GBX | -0.02% | +8.00% | +14.81% |
09:01am | AstraZeneca's Blood Cancer Combo Extends Progression-free Survival in Late-stage Study | MT |
30/04 | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.81% | 236B | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B | |
-5.59% | 154B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Drugmakers slash prices to obtain China's bulk-buy contracts -state media